Rus
Eng 
Congratulations to Prof. Yury Gogotsi for being elected to the MRS Board of Directors!
This position will allow him to help establish the direction of the societyas it strives to build “a dynamic, interactive, global community of materials researchers to advance technical excellence by providing a framework in which the materials disciplines can convene, collaborate, integrate and advocate.”
Yury Gogotsi is currently Distinguished University professor and Trustee Chair in the Department of Materials Science and Engineering at Drexel University and Director of A. J. Drexel Nanomaterials Institute.
Prof. Yury Gogotsi has been active in MRS for more than 20 years. He has been the organizer for various MRS symposia (2014 De Novo Carbon Nanomaterials II Symposium, 2009 Symposium on Materials Challenges Facing Electrical Energy Storage, and others), delivered numerous invited talks and was selected for the prestigious Fred Kavli Distinguished Lectureship in Nanotechnology in 2014. Much of his involvement was focused on students. He was the founding advisor of the MRS Student Chapter at Drexel. Moreover, he has advised some of the top students who have been awarded MRS Gold and Silver Graduate Student Awards, as well as two of three Arthur Nowick award winners. He served as chair of the MRS Student Chapters subcommittee in 2011-2015, increasing the total number of student chapters from about 60 to over 90, and introducing international chapters (16 total).
Source: http://www.mrs.org/elections-2015-results
Prof. Gogotsi′s Candidate’s Statement
Here we demonstrate a new developed method for depositing Ti3C2Tx MXenes onto hydrophobic electrospun PCL membranes using oxygen plasma treatment. These novel patches hold tremendous potential for providing mechanical support to damaged heart tissue and enabling electrical signal transmission,thereby mimicking the crucial electroconductivity required for normal cardiac function. After a detailed investigation of scaffold-to-cell interplay, including electrical stimulation, novel technology has the potential for clinical application not only for cardiac regeneration, but also as neural and muscular tissue substitutes.
MX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications. 
CanbioSe Project Meeting and Project Workshop was held at European Institute of Membranes (IEM), University of Montpellier, France on September 26-27, 2023. The workshop was focused on the theme of "Commercializing Biosensors, Intellectual Property, and Knowledge Transfer from Academia to Industry.
Dr. Oleksiy Gogotsi and Veronika Zahorodna visited IEEE NAP 2023 conference held in Bratislava on September 10-15, 2023. The prime focus of the IEEE NAP-2023 was on nanoscale materials with emphasis on interdisciplinary research exploring and exploiting their unique physical and chemical proprieties for practical applications.
Director of MRC and Carbon-Ukraine Dr. Oleksiy Gogotsi visited CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA). He meet with Dr. Pierluigi Bilotto, Dr. Chriatian Pichler and their colleagues, discussing novel materials and r&d activities for new technologies.
MX-MAP Session was held during the YUCOMAT Conference 2023 titled: "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.
CANBIOSE project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed secondment visit to project partner organization European Institute of Membranes in Montpellier (France) on August -September 2023.
MRC researchers Dr. Oleksiy Gogotsi and Veronika Zahorodna were visiting Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to close collaboration with AMU team led by Dr. Igor Iatsunskiy. 
Meeting during the MXene international conference held in Drexel University on Aug. 3, 2022, and discussing the roadmap for launching MX-MAP research project on MXenes for medical applications.